Status:
UNKNOWN
fNIRs, Listening Effort, and Speech Intelligibility
Lead Sponsor:
Sonova AG
Collaborating Sponsors:
Toronto Metropolitan University
Conditions:
Hearing Loss
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The purpose of the current study is to measure oxygenation in the PFC using fNIRS in a sample of older adults with hearing loss. Adults with hearing loss will be asked to repeat the final word from lo...
Detailed Description
See above.
Eligibility Criteria
Inclusion
- Adults (18-99 years) with ≥3 months hearing aid experience
- binaural, symmetric, sensorineural N2 (mild) to N6 (severe) hearing loss
- fluent in English
Exclusion
- children/teenagers
- normal hearing or hearing loss exceeding N6 (severe) by 10 dB
Key Trial Info
Start Date :
May 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05330585
Start Date
May 3 2022
End Date
December 1 2022
Last Update
September 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sonova Innovation Centre Toronto
Mississauga, Ontario, Canada, L5L1J3